Literature DB >> 26507959

Characterizing the Lateral Border of the Frontalis for Safe and Effective Injection of Botulinum Toxin.

You-Jin Choi1, Sung-Yoon Won1, Jae-Gi Lee1, Kyung-Seok Hu1, Sung-Taek Kim1, Tanvaa Tansatit1, Hee-Jin Kim1.   

Abstract

BACKGROUND: The forehead is a common site for injection of botulinum neurotoxin type A (BoNT-A) to treat hyperactive facial muscles. Unexpected side effects of BoNT-A injection may occur because the anatomy of the forehead musculature is not fully characterized.
OBJECTIVES: The authors described the lateral border of the frontalis in terms of facial landmarks and reference lines to determine the safest and most effective forehead injection sites for BoNT-A.
METHODS: The hemifaces of 49 embalmed adult Korean cadavers were dissected in a morphometric analysis of the frontalis. L2 was defined in terms of FT (the most protruding point of the frontotemporal region), L0 (the line connecting the infraorbital margin with the tragus), and L1 (the line parallel to L0 and passing through FT) such that L2 was positioned 45° from L1 and passed through FT.
RESULTS: The distance from FT to the superior margin of the orbicularis oculi was 12.3 ± 3.3 mm. The frontalis extended more than 5 cm along L2 in 49 of 49 cases (100%), more than 6 cm in 47 cases (95.9%), more than 7 cm in 34 cases (69.4%), more than 8 cm in 11 cases (22.4%), and more than 9 cm in 3 cases (6.1%). The lateral border of the frontalis ran parallel to and within 1 cm of the medial side of L2.
CONCLUSIONS: Surface anatomy mapping can assist with predicting the lateral border of the frontalis to minimize the side effects and maximize the efficiency of BoNT-A injections into the forehead.
© 2015 The American Society for Aesthetic Plastic Surgery, Inc. Reprints and permission: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26507959      PMCID: PMC5127457          DOI: 10.1093/asj/sjv190

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  11 in total

Review 1.  Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.

Authors:  Z Paul Lorenc; Stacy Smith; Mark Nestor; Diane Nelson; Amir Moradi
Journal:  Aesthetic Plast Surg       Date:  2013-07-12       Impact factor: 2.326

Review 2.  Diffusion, spread, and migration of botulinum toxin.

Authors:  Juan Ramirez-Castaneda; Joseph Jankovic; Cynthia Comella; Khashayar Dashtipour; Hubert H Fernandez; Zoltan Mari
Journal:  Mov Disord       Date:  2013-07-18       Impact factor: 10.338

3.  Consensus recommendations on the aesthetic usage of botulinum toxin type A in Asians.

Authors:  Bong Kyun Ahn; Youn Sung Kim; Hong Jig Kim; Nark Kyoung Rho; Hei Sung Kim
Journal:  Dermatol Surg       Date:  2013-10-11       Impact factor: 3.398

4.  An anatomical approach to glabellar rhytids.

Authors:  M R Macdonald; J H Spiegel; R B Raven; S S Kabaker; C S Maas
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-12

5.  Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.

Authors:  Andrew Blumenfeld; Stephen D Silberstein; David W Dodick; Sheena K Aurora; Catherine C Turkel; William J Binder
Journal:  Headache       Date:  2010-10       Impact factor: 5.887

6.  Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.

Authors:  Jean D A Carruthers; Richard G Glogau; Andrew Blitzer
Journal:  Plast Reconstr Surg       Date:  2008-05       Impact factor: 4.730

7.  A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.

Authors:  Alastair Carruthers; Jean Carruthers; J Cohen
Journal:  Dermatol Surg       Date:  2003-05       Impact factor: 3.398

8.  Cosmetic Microdroplet Botulinum Toxin A Forehead Lift: A New Treatment Paradigm.

Authors:  Kenneth D Steinsapir; Daniel Rootman; Allan Wulc; Catherine Hwang
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 Jul-Aug       Impact factor: 1.746

9.  A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.

Authors:  J Alastair Carruthers; Nicholas J Lowe; M Alan Menter; John Gibson; Marian Nordquist; Julie Mordaunt; Patricia Walker; Nina Eadie
Journal:  J Am Acad Dermatol       Date:  2002-06       Impact factor: 11.527

10.  A proposal to prevent the "Mephisto sign" side effect of botulinum toxin type A injection in chronic migraine.

Authors:  Eunae S Cho; Jae Young Hwang; Seong Taek Kim
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

View more
  3 in total

Review 1.  Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.

Authors:  Mark Nestor; Glynis Ablon; Andy Pickett
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

Review 2.  The Practical Use of AbobotulinumtoxinA in Aesthetics.

Authors:  Michael A C Kane; Gary Monheit
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

3.  The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.

Authors:  Mark S Nestor; David Arnold; Daniel Fischer
Journal:  J Cosmet Dermatol       Date:  2020-09-16       Impact factor: 2.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.